Mitulkumar A. Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mitulkumar A. Patel has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Joseph F. Krzyzaniak
Pfizer Inc, Worldwide Research and Development, Groton, Connecticut 06340, United States
3 shared publications- Lynne S. Taylor
Department of Industrial and Molecular Pharmaceutics, College of Pharmacy, Purdue University, West Lafayette, USA
3 shared publications Sheri L. Shamblin
Pfizer Inc, Worldwide Research and Development, Groton, Connecticut 06340, United States
3 shared publicationsSuman Luthra
Pfizer Inc, Worldwide Research and Development, Cambridge, Massachusetts 02139, United States
3 shared publicationsAbhay H. Pande
2 shared publications- Keith Chadwick
Department of Industrial and Physical Pharmacy, Purdue University, 575 Stadium Mall Drive, West Lafayette, IN 47907, USA
2 shared publications
Latest Publications
- 5 October 2018
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 18 (11) , 7027-7040
Assessing the Risk of Salt Disproportionation Using Crystal Structure and Surface Topography Analysis
- 5 October 2018
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 18 (11) , 7027-7040
Assessing the Risk of Salt Disproportionation Using Crystal Structure and Surface Topography Analysis
- 1 July 2018
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 546 (1-2) , 226-234
Effect of excipient properties, water activity, and water content on the disproportionation of a pharmaceutical salt
- 1 July 2018
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 546 (1-2) , 226-234
Effect of excipient properties, water activity, and water content on the disproportionation of a pharmaceutical salt
- 20 December 2017
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 15 (1) , 40-52
Impact of Solid-State Form on the Disproportionation of Miconazole Mesylate
Approximately 50% of solid oral dosage forms utilize salt forms of the active pharmaceutical ingredient (API). A major challenge with the salt form is its tendency to disproportionate to produce the unionized API form, decreasing the solubility and negatively impacting product stability. However, many of the factors dictating the tendency of a given salt to undergo disproportionation remain to be elucidated. In particular, the role of the solid-state properties of the salt on the disproportionation reaction is unknown. Herein, various solid forms of a model salt, miconazole mesylate (MM), were evaluated for their tendency to undergo disproportionation when mixed with basic excipients, namely tribasic sodium phosphate dodecahydrate (TSPd) and croscarmellose sodium (CCS), and exposed to moderate relative humidity storage conditions. It was observed that the rate and extent of salt disproportionation were significantly different for the various solid forms of MM. As expected, the amorphous salt was highly susceptible to disproportionation, while the dihydrate salt form was resistant to conversion under the conditions tested. In addition, binary excipient blends of amorphous and anhydrous forms exhibited a reduced extent of disproportionation at a higher relative humidity storage condition. This was due to the competitive kinetics between disproportionation to the free base and conversion to the dihydrate salt form. The results of this study provide important insights into the impact of solid-state form on susceptibility to disproportionation that can be utilized for rationally designing robust pharmaceutical formulations.
- 20 December 2017
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 15 (1) , 40-52
Impact of Solid-State Form on the Disproportionation of Miconazole Mesylate
Approximately 50% of solid oral dosage forms utilize salt forms of the active pharmaceutical ingredient (API). A major challenge with the salt form is its tendency to disproportionate to produce the unionized API form, decreasing the solubility and negatively impacting product stability. However, many of the factors dictating the tendency of a given salt to undergo disproportionation remain to be elucidated. In particular, the role of the solid-state properties of the salt on the disproportionation reaction is unknown. Herein, various solid forms of a model salt, miconazole mesylate (MM), were evaluated for their tendency to undergo disproportionation when mixed with basic excipients, namely tribasic sodium phosphate dodecahydrate (TSPd) and croscarmellose sodium (CCS), and exposed to moderate relative humidity storage conditions. It was observed that the rate and extent of salt disproportionation were significantly different for the various solid forms of MM. As expected, the amorphous salt was highly susceptible to disproportionation, while the dihydrate salt form was resistant to conversion under the conditions tested. In addition, binary excipient blends of amorphous and anhydrous forms exhibited a reduced extent of disproportionation at a higher relative humidity storage condition. This was due to the competitive kinetics between disproportionation to the free base and conversion to the dihydrate salt form. The results of this study provide important insights into the impact of solid-state form on susceptibility to disproportionation that can be utilized for rationally designing robust pharmaceutical formulations.
- 1 October 2017
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 532 (1) , 166-176
The discovery and investigation of a crystalline solid solution of an active pharmaceutical ingredient
- 1 October 2017
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 532 (1) , 166-176
The discovery and investigation of a crystalline solid solution of an active pharmaceutical ingredient
- 7 August 2017
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 17 (9) , 4613-4621
Predicting the Nucleation Induction Time Based on Preferred Intermolecular Interactions
- 7 August 2017
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 17 (9) , 4613-4621
Predicting the Nucleation Induction Time Based on Preferred Intermolecular Interactions
- 1 January 2017
- Published by Elsevier in Carbohydrate Polymers
- Vol. 155, 362-371
The effect of ionotropic gelation residence time on alginate cross-linking and properties
- 1 January 2017
- Published by Elsevier in Carbohydrate Polymers
- Vol. 155, 362-371
The effect of ionotropic gelation residence time on alginate cross-linking and properties
- 28 October 2016
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 16 (12) , 6933-6940
Utilization of Surface Equilibria for Controlling Heterogeneous Nucleation: Making the “Disappeared” Polymorph of 3-Aminobenzensulfonic Acid “Reappear”
- 28 October 2016
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 16 (12) , 6933-6940
Utilization of Surface Equilibria for Controlling Heterogeneous Nucleation: Making the “Disappeared” Polymorph of 3-Aminobenzensulfonic Acid “Reappear”
- 19 May 2015
- Published by Royal Society of Chemistry (RSC) in CrystEngComm
- Vol. 18 (7) , 1118-1122
Polymorphism of vanillin revisited: the discovery and selective crystallization of a rare crystal structure
While polymer induced heterogeneous nucleation (PIHn) has been shown to be a powerful tool for crystallization control and polymorph screening the factors influencing PIHn, such as solvent selection, supersaturation and method of crystallization are not well understood. Herein, we report on the use of PIHn to selectively crystallize a new and rare crystal structure of vanillin. Nearly 65 years ago, Walter McCrone postulated vanillin to be trimorphic. However, only one crystal form, Form I, had been structurally characterized to this point. Form II crystallizes in the space group Pna21 with four molecules in the asymmetric unit. Achiral molecules exhibiting such crystal structures account for less than 0.008% of all organic entries in the Cambridge Structural Database. Polymorphic control by PIHn was observed to be highly dependent on the method of crystallization. In the presence of poly(acrylic acid) and poly(methyl methacrylate) micro-particles the thermodynamically stable Form I was crystallized from isopropanol by quench cooling, while metastable Form II was obtained by slow evaporation. To our knowledge this is the first deliberate study to highlight the influence of crystallization method on PIHn.
- 19 May 2015
- Published by Royal Society of Chemistry (RSC) in CrystEngComm
- Vol. 18 (7) , 1118-1122
Polymorphism of vanillin revisited: the discovery and selective crystallization of a rare crystal structure
While polymer induced heterogeneous nucleation (PIHn) has been shown to be a powerful tool for crystallization control and polymorph screening the factors influencing PIHn, such as solvent selection, supersaturation and method of crystallization are not well understood. Herein, we report on the use of PIHn to selectively crystallize a new and rare crystal structure of vanillin. Nearly 65 years ago, Walter McCrone postulated vanillin to be trimorphic. However, only one crystal form, Form I, had been structurally characterized to this point. Form II crystallizes in the space group Pna21 with four molecules in the asymmetric unit. Achiral molecules exhibiting such crystal structures account for less than 0.008% of all organic entries in the Cambridge Structural Database. Polymorphic control by PIHn was observed to be highly dependent on the method of crystallization. In the presence of poly(acrylic acid) and poly(methyl methacrylate) micro-particles the thermodynamically stable Form I was crystallized from isopropanol by quench cooling, while metastable Form II was obtained by slow evaporation. To our knowledge this is the first deliberate study to highlight the influence of crystallization method on PIHn.
- 20 December 2013
- Published by Springer Nature
- p. 691-731
Activation Approaches on Delivery of Imaging and Therapeutic Agents
- 20 December 2013
- Published by Springer Nature
- p. 691-731
Activation Approaches on Delivery of Imaging and Therapeutic Agents
- 1 December 2013
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1831 (12) , 1714-1720
Oxidized-phospholipids in reconstituted high density lipoprotein particles affect structure and function of recombinant paraoxonase 1
- 1 December 2013
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1831 (12) , 1714-1720
Oxidized-phospholipids in reconstituted high density lipoprotein particles affect structure and function of recombinant paraoxonase 1